Long-Term Health Outcomes of People with HIV Engaged in Chemsex: A Prospective Cohort Study on Drug Use, Sexual Behaviour, Sexually-Transmitted Infections and Vulnerability [0.03%]
与化学性行为有关的HIV患者的长期健康结局：一项关于药物使用、性行为、性传播感染和脆弱性的前瞻性队列研究
Lorena De La Mora,Montserrat Laguno,Berta Torres et al.
Lorena De La Mora et al.
Introduction: Chemsex, the intentional use of drugs to enhance sexual experiences among gay, bisexual, and other men who have sex with men (gbMSM), is linked to high-risk sexual behaviours and increased sexually transmitt...
A Cluster Randomized Study to Explore Case Definitions, Clinical Course and Consequences of RSV in Community-Dwelling Adults Aged ≥ 50 Years [0.03%]
一项群随机研究：探索社区居住的≥50岁老年人RSV病例定义、临床过程和后果
Alexander Domnich,Francesco Lapi,Andrea Orsi et al.
Alexander Domnich et al.
Introduction: In Europe, surveillance of respiratory syncytial virus (RSV) has been recently incorporated into existing influenza monitoring platforms that are based on influenza-like illness (ILI) or acute respiratory in...
The Burden of Human Metapneumovirus (hMPV) Disease in Older and High-Risk Adults in Developed Countries: A Systematic Literature Review [0.03%]
发达国家老年人和高危成人呼吸道合胞病毒（hMPV）疾病负担的系统文献回顾
Ajoke Sobanjo-Ter Meulen,Aura V Gutierrez,Ornella Ruiz et al.
Ajoke Sobanjo-Ter Meulen et al.
Introduction: Human metapneumovirus (hMPV) causes respiratory infections in individuals of all age groups. While the evidence on hMPV epidemiology is growing, the hMPV burden in adults has not been synthesised. We conduct...
Estimating the Value of Aztreonam-Avibactam in Treating Metallo-beta-Lactamase-Producing Enterobacterales Infections in Spain Using the STEDI AMR Value Framework [0.03%]
使用STEDI AMR价值框架估算Aztreonam-Avibactam在西班牙治疗产金属β-内酰胺酶肠杆菌目感染中的价值
Ricard Ferrer,Sonia Luque,Luis Martínez-Martínez et al.
Ricard Ferrer et al.
Introduction: Treatments for serious infections caused by multidrug-resistant gram-negative bacteria, including metallo-β-lactamase-producing Enterobacterales (MBL-EB), are limited and aztreonam with avibactam (ATM-AVI) ...
Early Prediction of In-Hospital Mortality in Patients with Acute Infections: Development of the Acute Severity Infection Score (ASIs) [0.03%]
急性感染患者住院死亡的早期预测：急性 severity 感染评分（ ASIs ）的制定
Alessio Comitangelo,Alfredo Vozza,Giovanna Ditaranto et al.
Alessio Comitangelo et al.
Introduction: Early prognostic stratification in patients hospitalized for acute infections is a major clinical challenge. Existing tools, such as the Sequential Organ Failure Assessment (SOFA) score and Charlson Comorbid...
Exploring Human Use of Monoclonal Antibodies Against Critical Bacteria: A Scoping Review of Clinical Trials [0.03%]
针对重要细菌的人源单克隆抗体临床应用研究：系统综述
Marco Piscaglia,Giovanni Scaglione,Camilla Genovese et al.
Marco Piscaglia et al.
Introduction: The global spread of multidrug-resistant organisms (MDROs), particularly the World Health Organization (WHO) priority pathogens, poses a major challenge to infection treatment, necessitating alternative ther...
Meital Elbaz,Dafna Yahav,Yair Mina et al.
Meital Elbaz et al.
Progressive multifocal leukoencephalopathy (PML) is a devastating and often fatal central nervous system infection caused by John Cunningham polyomavirus virus (JCPyV). PML results from JCPyV reactivation in the setting of impaired cellular...
Clinical Characteristics and Prognosis of AIDS Complicated with Talaromycosis marneffei Infection: a Single-Center Retrospective Study [0.03%]
马尔尼菲青霉菌病合并艾滋病的临床特点及预后分析：单中心回顾性研究
Zhangyan Weng,Yijie Lin,Wenliang Dai et al.
Zhangyan Weng et al.
Introduction: The objective of the study was to determine the clinical features and prognostic risk factors of acquired immunodeficiency syndrome (AIDS) combined with Talaromyces marneffei (TM) infection. ...
Estimating the Public Health and Economic Impact of Immunisation with Nirsevimab or Maternal Immunisation for the Prevention of RSV-Related Outcomes Over Infants' First RSV Season in the UK [0.03%]
估算英国婴儿第一个呼吸道合胞病毒(RSV)季节接种尼塞维单抗或母体免疫以预防RSV相关结果的公共卫生和经济影响
Mersha Chetty,Paul Costello,Benjamin Yarnoff et al.
Mersha Chetty et al.
Introduction: Respiratory syncytial virus (RSV) poses a significant health burden on infants, particularly during their first RSV season. Immunoprophylactic strategies, such as the administration of nirsevimab, a long-act...
Complementary Strategy of Maternal Immunization with RSVpreF Vaccine and Monoclonal Antibodies for the Prevention of Respiratory Syncytial Virus Among Italian Infants: A Cost-Effectiveness Assessment [0.03%]
RSVpreF疫苗联合单克隆抗体用于意大利婴儿呼吸道合胞病毒预防的补充策略：一种成本效益评估
Barbara Polistena,Fabio Midulla,Giovanni Sotgiu et al.
Barbara Polistena et al.
Introduction: Respiratory Syncytial Virus (RSV) is a leading cause of severe lower respiratory tract infections and is one of the primary causes of hospitalization in high income countries and death among children aged ≤...